The NHS is not making the most of its spending power to save money in purchasing medical equipment and consumables.
This is according to a new report (NHS Supply Chain and efficiencies in procurement) from the National Audit Office (NAO), which has found the NHS has continued to spend more than £3 billion outside NHS Supply Chain, its purpose-built procurement route, as customer satisfaction with Supply Chain has declined and sits below target.
Among the reasons given for Trusts not choosing to purchase through Supply Chain, 71.8% of customers said the products they wanted were not available. The performance of eDirect – a procurement route accounting for around £1.5 billion of orders via Supply Chain in 2022-23 – also comes in for criticism. Orders via this route were delivered on average 22 days late between June 2022 and March 2023.
The NAO report examined how NHS Supply Chain is making efficiencies across NHS procurement, and whether it has achieved its objectives of saving money and increasing its share of products bought through it by the NHS. At its inception in 2019, DHSC set NHS Supply Chain a target to deliver £2.4 billion savings by 2023-24. As of 2022-23, it told the NAO that it had exceeded this target – but although Supply Chain reported progress against this target to NHSE on a quarterly basis, neither NHSE nor the DHSC has validated or checked these savings.
NHS Supply Chain has used different methods to report savings to different audiences, which could also cause confusion. Some NHS Trusts themselves said that they did not recognise Supply Chain’s claimed savings and this issue is causing frustration and mistrust. In summer 2023, NHSE, NHS Supply Chain, Trusts and stakeholders worked together to develop a new methodology for reporting savings which should be ready from April 2024. Supply Chain is now pursuing a new savings target of £1 billion from January 2022 to 2030 (£500 million by 2026).
Market share
There is no reliable baseline against which to estimate whether NHS Supply Chain achieved its 80% market share target. Supply Chain reported progress against this target until 2021-22, however DHSC and NHSE did not reassess the value of the market during this period. As a result, the market share figure was most likely overstated. Supply Chain did not report a market share figure for 2022-23 as it no longer had confidence in the original total market value. Supply Chain has established a new baseline for estimating its market share, although this is based on incomplete data from Trusts. For 2023-24, NHS Supply Chain estimates that annual NHS spending on products is around £8 billion.
Trusts spend approximately £3.4 billion outside of NHS Supply Chain’s function, and the NAO reports there is a still lot of variation in the prices they pay. For example, for each hip replacement stem part purchased by the NHS in 2022-23, individual Trusts paid up to £490, with a median price of £333. Supply Chain’s price for the same product was £258 which was the lowest price for that product.
Transforming Supply Chain
NHS Supply Chain is working to address the challenges highlighted in this report and is implementing a transformation programme. However, the NAO flags up weaknesses in how it is managing this transformation, with an over-reliance on the Chief Executive Officer and slow recruitment of senior staff. Supply Chain has set out what it considers it needs from NHSE for transformation to succeed and to achieve £1 billion savings. While NHSE is making progress towards most of these ‘asks’, it could do more.
The NAO recommends that NHSE should use its data on Trusts’ spending to understand and challenge why Trusts are not using NHS Supply Chain and incentivise and encourage greater use of NHS Supply Chain, and that NHS Supply Chain should improve its understanding of why some customers are unsatisfied with its services and develop a targeted action plan to make substantial improvements in satisfaction.
“Delivering the right products for the NHS, on time and at the best available price is essential to make every pound count for patients. The NHS has enormous buying power, but it is not yet making the most of it,” says Gareth Davies, Head of the NAO.
“Supply Chain needs to do more to deliver, and to show that it is delivering, for the NHS. In response, Trusts need to make use of the NHS’s buying power to secure the lower costs Supply Chain can bring, with support and clear direction from NHSE.”
